- 
				
Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease
 - 
				
Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment
 - 
				
Quality of life and living with Parkinson’s in Ireland
 - 
				
Quality of life of Parkinson’s disease patients in a tertiary hospital in Hong Kong
 - 
				
Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment
 - 
				
Quantification of postural stability in Parkinson’s disease patients utilizing mobile technology
 - 
				
Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease
 - 
				
Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease
 - 
				
Quantifying daily living transitions in patients with Parkinson’s disease using a body-fixed sensor
 - 
				
Quantifying turning behavior in Parkinson’s disease patients using mobile technology
 - 
				
Quantitative analysis of tremor in patients with cerebellar and brainstem lesions
 - 
				
Quantitative assessment of advanced therapies in Parkinson’s disease using the Parkinson kinetigraph (PKG)
 - 
				
Quantitative assessment of DBS-induced gait disorder in patients with essential tremor
 - 
				
Quantitative measurements of deficit type and severity in focal embouchure dystonia
 - 
				
Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy
 
2016 International Congress
June 19-23, 2016. Berlin, Germany.
